ABSTRACT NUMBER: ESOC2026A1232 CAROTID ATHEROSCLEROTIC PLAQUE WIDTH AND PLAQUE PROGRESSION AS MARKERS FOR RISK OF DEATH

Abstract Background and aims Severity of carotid stenosis and RADS classification of atherosclerotic plaque are markers for stroke and cardiac death. ANTIQUE study (ClinicalTrials ID:NCT02360137) aimed to analyze more plaque characteristics. The aim of our analysis was to evaluate the relationship between both carotid atherosclerotic plaque width and plaque progression and the risk of death during 10-year follow-up in patients from ANTIQUE study. Methods We analyzed 10-year follow-up data from patients enrolled in the ANTIQUE study. All participants underwent annual B-mode ultrasound with measurement of maximal carotid plaque width in transverse view. Plaques were categorized by maximal width (A: ≤0.25; B: 0.26-0.35; C: 0.36-0.45; D: 0.46-0.55; E: >0.55 mm). Plaque progression was defined as difference between first and last measurements and classified as stable plaques (1: ≤0.2 mm), minor (2: 0.21–1.0 mm), or major (3: >1.0 mm) plaque progressions. Dates and causes of death were obtained from the national patient registry. Survival was assessed using Kaplan–Meier analysis and compared with log-rank test. Results Total of 1,652 patients (749 men; mean age 68.7±9.4 years) were included to the analysis. Within 10 years, 537 (32.5%) patients died (294 males; mean age 74.4+/-6.9 years). Increasing plaque width and greater plaque progression were both significantly associated with higher mortality risk (both p<0.01; Figure 1). These associations were consistent across plaque size and progression categories. Conclusions Carotid plaque width and plaque progression are strong predictors of long-term mortality. Routine longitudinal plaque measurement may improve risk stratification and support personalized preventive strategies in patients with carotid atherosclerosis. Conflict of interest David Skoloudik: nothing to disclose. David Pakizer: nothing to disclose. Istvan Szegedi: nothing to disclose. David Netuka: nothing to disclose. Figure 1 - belongs to Results

Authors

Institutions

Publication Details

Journal
European Stroke Journal
Published
2026-05-01
DOI
https://doi.org/10.1093/esj/aakag023.602
Primary Topic
Cerebrovascular and Carotid Artery Diseases
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

ABSTRACT NUMBER: ESOC2026A1232 CAROTID ATHEROSCLEROTIC PLAQUE WIDTH AND PLAQUE PROGRESSION AS MARKERS FOR RISK OF DEATH

David Pakizer, István Szegedi, David Školoudík, David Netuka
European Stroke Journal
Cerebrovascular and Carotid Artery Diseases
article

ABSTRACT NUMBER: ESOC2026A1232 CAROTID ATHEROSCLEROTIC PLAQUE WIDTH AND PLAQUE PROGRESSION AS MARKERS FOR RISK OF DEATH

David Pakizer, István Szegedi, David Školoudík, David Netuka
article en

Abstract

Abstract Background and aims Severity of carotid stenosis and RADS classification of atherosclerotic plaque are markers for stroke and cardiac death. ANTIQUE study (ClinicalTrials ID:NCT02360137) aimed to analyze more plaque characteristics. The aim of our analysis was to evaluate the relationship between both carotid atherosclerotic plaque width and plaque progression and the risk of death during 10-year follow-up in patients from ANTIQUE study. Methods We analyzed 10-year follow-up data from patients enrolled in the ANTIQUE study. All participants underwent annual B-mode ultrasound with measurement of maximal carotid plaque width in transverse view. Plaques were categorized by maximal width (A: ≤0.25; B: 0.26-0.35; C: 0.36-0.45; D: 0.46-0.55; E: >0.55 mm). Plaque progression was defined as difference between first and last measurements and classified as stable plaques (1: ≤0.2 mm), minor (2: 0.21–1.0 mm), or major (3: >1.0 mm) plaque progressions. Dates and causes of death were obtained from the national patient registry. Survival was assessed using Kaplan–Meier analysis and compared with log-rank test. Results Total of 1,652 patients (749 men; mean age 68.7±9.4 years) were included to the analysis. Within 10 years, 537 (32.5%) patients died (294 males; mean age 74.4+/-6.9 years). Increasing plaque width and greater plaque progression were both significantly associated with higher mortality risk (both p<0.01; Figure 1). These associations were consistent across plaque size and progression categories. Conclusions Carotid plaque width and plaque progression are strong predictors of long-term mortality. Routine longitudinal plaque measurement may improve risk stratification and support personalized preventive strategies in patients with carotid atherosclerosis. Conflict of interest David Skoloudik: nothing to disclose. David Pakizer: nothing to disclose. Istvan Szegedi: nothing to disclose. David Netuka: nothing to disclose. Figure 1 - belongs to Results

European Stroke JournalVol. 11(Supplement_1)
University of Ostrava (CZ), Military University Hospital Prague (CZ)
Good health and well-being
Openalex Percentile: Top 8%
Cerebrovascular and Carotid Artery Diseases
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.